Epizyme, Inc. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

Epizyme, Inc. has filed 829 SEC EDGAR filings since 22 Mar 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 726-750 of 829 matching filings.

Per page

25

Current page

30

S-1/A File 333-193569

S-1/A

Filing date: 03 Feb 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Jan 2014
Reporting date: 28 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Jan 2014
Reporting date: 28 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Jan 2014
Reporting date: 28 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Jan 2014
Reporting date: 28 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-193569

S-1/A

Filing date: 28 Jan 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1 File 333-193569

FORM S-1

Filing date: 27 Jan 2014
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jan 2014
Reporting date: 13 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35945

FORM 8-K

Filing date: 07 Jan 2014
Reporting date: 06 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Jan 2014
Reporting date: 06 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Jan 2014
Reporting date: 02 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 17 Dec 2013
Reporting date: 16 Dec 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Dec 2013
Reporting date: 02 Dec 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-87481

EPIZYME, INC.

Filing date: 21 Nov 2013
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2013
Reporting date: 14 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .